^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

RAS mutation

9ms
HER-2 (Human epidermal growth factor receptor 2) • CLDN18 (Claudin 18) • RAS (Rat Sarcoma Virus)
|
HER-2 overexpression • HER-2 mutation • RAS mutation • CLDN18.2 overexpression
10ms
Clinical
|
HER-2 (Human epidermal growth factor receptor 2) • RAS (Rat Sarcoma Virus)
|
RAS mutation • RAS wild-type
|
Enhertu (fam-trastuzumab deruxtecan-nxki)
12ms
Clinical
|
RAS (Rat Sarcoma Virus)
|
RAS mutation
|
Lynparza (olaparib) • Koselugo (selumetinib)
1year
RAS (Rat Sarcoma Virus)
|
EGFR mutation • RAS mutation
1year
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation • EGFR mutation • RAS mutation
over1year
ASXL1 (ASXL Transcriptional Regulator 1) • RAS (Rat Sarcoma Virus)
|
RAS mutation • ASXL1 mutation
|
Venclexta (venetoclax) • azacitidine • decitabine
over1year
FLT3 (Fms-related tyrosine kinase 3) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • RAS (Rat Sarcoma Virus)
|
KIT mutation • RAS mutation
over1year
KRAS (KRAS proto-oncogene GTPase) • NRAS (Neuroblastoma RAS viral oncogene homolog) • NF1 (Neurofibromin 1) • PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11)
|
KRAS mutation • NRAS mutation • RAS mutation
|
hydroxyurea
over1year
KRAS (KRAS proto-oncogene GTPase) • RAS (Rat Sarcoma Virus)
|
KRAS mutation • RAS mutation